Get these analyses to your inbox — https://axialfc.substack.com/ This is a newsletter for new financing events with some simple analysis. More well thought out work can be found at — https://axial.substack.com/
Axial invests and partners in early-stage life sciences companies. If you or someone you know has a great idea or company in life sciences, Axial would be excited to get to know you and possibly invest in your vision and company — info@axialsprawl.com
Life Sciences Financings and Commentary #11 — June 6, 2020 — June 12, 2020
Financings
Number of deals: 20 & Total capital invested: $742.5M
- Alpha Health raised $20M led by a16z Bio to build a revenue cycle management product. Tough market.
- Autobahn Therapeutics raised $76M co-led by ARCH Venture Partners and Cowen Healthcare Investments to develop prodrug small molecule medicines to restore myelination levels of neurons to treat multiple sclerosis and other CNS diseases.
- Binah.ai raised $13.5M led by Maverick Ventures to build software tools for video-based health/wellness products.
- C2i Genomics raised $12M led by Casdin Capital to translate genome-wide liquid biopsy technologies from Weill Cornell to measure oncology minimal residual disease —…
